Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02808702 · ClinicalTrials.gov registry record · NA
Brain Correlates of Self-Focused Processing
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT02808702: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02808702 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02808702, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether neuroimaging-based markers of maladaptive self-focused processing are better predictors of treatment response to cognitive-behavioral therapy than behavioral markers.
Interventions
- BEHAVIORAL Cognitive-behavioral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02808702
The ClinicalTrials.gov registry entry for NCT02808702 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive-behavioral therapy is the first listed.
NCT02808702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02808702 about?
NCT02808702 is a clinical study titled "Brain Correlates of Self-Focused Processing". The purpose of this study is to determine whether neuroimaging-based markers of maladaptive self-focused processing are better predictors of treatment response to cognitive-behavioral therapy than behavioral markers.
What is the current status of trial NCT02808702?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2017-05-01. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT02808702?
The interventions under investigation include: Cognitive-behavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02808702?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.